FDA Inspection
Miracles in SightMiracles in Sight – FDA Inspection, Jul 9, 2009
Record Details
This FDA Inspection record concerns Miracles in Sight, with an inspection on July 9, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Miracles in Sight
- Inspection Date
- July 9, 2009
- Product Type
- Biologics
View Company Profile
ID · 61eea235-c0db-4ab3-82fd-89f104ea229e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 599088
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.60(b)Identified as quarantined, distinguishable
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Miracles in Sight
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2025 | Not classified | Atlanta District Office | |
| September 18, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 30, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 11, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Miracles in Sight
- FDA Inspection 1264026 - 2025-03-10
- FDA Inspection 1218383 - 2023-09-18
- FDA Inspection 1118762 - 2020-01-30
- FDA Inspection 1023209 - 2017-08-11
- FDA Inspection 943193 - 2015-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.